aNSCLSadvanced non-small cell lung cancer(English)can be targeted with MET inhibitors including tepotinib, capmatinib, savolitinib, and crizotinibDOR, MAIC, MET, NSCLC, OS, PFSPulmonology, Oncologyhttps://doi.org…325-022-02163-9« ANSANSD »